A detailed history of Cooper Financial Group transactions in Insulet Corp stock. As of the latest transaction made, Cooper Financial Group holds 894 shares of PODD stock, worth $237,017. This represents 0.03% of its overall portfolio holdings.

Number of Shares
894
Previous 1,132 21.02%
Holding current value
$237,017
Previous $228,000 8.77%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$180.69 - $239.01 $43,004 - $56,884
-238 Reduced 21.02%
894 $208,000
Q2 2024

Jul 15, 2024

BUY
$161.02 - $206.98 $182,274 - $234,301
1,132 New
1,132 $228,000
Q4 2023

Jan 16, 2024

BUY
$127.77 - $221.42 $144,763 - $250,868
1,133 New
1,133 $245,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.